Publications by authors named "Puhan Lu"

Claim this Profile
F
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.
Xiaohua Wu, Jing Wang, Danbo Wang, Guiling Li, Jieqing Zhang, Puhan Lu

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial.
Hua Xu, Xin Yao, Zhisong He, Hong Luo, Guiling Li, Puhan Lu

Target Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring Exon 14 Skipping Alterations.
Shun Lu, Jian Fang, Xingya Li, Lejie Cao, Jianying Zhou, Puhan Lu, Xian Luo

JTO Clin Res Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring exon 14 skipping alterations: a analysis of a pivotal phase 2 study.
Yongfeng Yu, Yongxin Ren, Jian Fang, Lejie Cao, Zongan Liang, Puhan Lu, Xian Luo, Shun Lu

Ther Adv Med Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Epitinib for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases: Open-Label Multicentre Dose-Expansion Phase Ib Study.
Qing Zhou, Mengzhao Wang, Helong Zhang, Qunying Hong, Xiaoqing Liu, Puhan Lu

Clin Lung Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The circulating ANGPTL8 levels show differences among novel subgroups of adult patients with diabetes and are associated with mortality in the subsequent 5 years.
Huajie Zou, Wu Duan, Zeqing Zhang, Xi Chen, Puhan Lu

Sci Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin upregulates betatrophin expression via PI3K/Akt pathway.
Puhan Lu, Xi Chen, Zeqing Zhang, Jianhua Zhang, Yan Yang

Sci Rep· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes.
Zeqing Zhang, Xi Chen, Puhan Lu, Jianhua Zhang, Yongping Xu

Cardiovasc Diabetol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIGIT negatively regulates inflammation by altering macrophage phenotype.
Xi Chen, Pu-Han Lu, Lei Liu, Ze-Min Fang, Wu Duan

Immunobiology· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.
Xi Chen, Puhan Lu, Wentao He, Jianhua Zhang, Lei Liu

J Clin Endocrinol Metab· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis